Form 4 for ZURA Zura Bio Ltd
Accepted 2023-02-15 00:00:00 ET · period of report 2023-02-10 · accession 0001104659-23-022452 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-02-15 | 2023-02-10 | ZURA | Sidhu Someit | CEO, Dir | J - Other | — | -2.34M | 967.4K | -71% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class B ordinary shares | 2023-02-10 | J | D | 2,337,630 | — | 967,370 | I See footnote | — | — | (F1) Shares were distributed by JATT Ventures, L.P. (the Sponsor") to various members. (F2) The Shares are beneficially owned by the Sponsor. Dr. Sidhu is the sole director of JATT Ventures, Ltd., the sole general partner of the Sponsor and has voting and investment discretion with respect to the ordinary shares held by the Sponsor and may be deemed to have shared beneficial ownership of the ordinary shares held directly by the Sponsor. |